Source: NASDAQ Stocks / 11 Oct 2024 05:42:12 America/Chicago
Fintel reports that on October 10, 2024, Barclays upgraded their outlook for CVS Health (BRSE:CVS) from Equal-Weight to Overweight.
https://www.nasdaq.com/articles/barclays-upgrades-cvs-health-brse-cvs